[Etiology of diabetic polyneuropathy].
D001162:Arteriosclerosis Obliterans / Q000150:complications; D001361:Avitaminosis / Q000150:complications; D050260:Carbohydrate Metabolism; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000378:metabolism; D016883:Diabetic Ketoacidosis / Q000209:etiology; D003929:Diabetic Neuropathies / Q000209:etiology*; D004342:Drug Hypersensitivity / Q000150:complications; D006801:Humans; D006943:Hyperglycemia / Q000150:complications; D007003:Hypoglycemia / Q000150:complications; D007004:Hypoglycemic Agents / Q000009:adverse effects; D000860:Hypoxia / Q000150:complications; D007866:Leg / Q000098:blood supply; D050356:Lipid Metabolism; D009419:Nerve Tissue Proteins / Q000378:metabolism; D010525:Peripheral Nerves / Q000378:metabolism; D011115:Polyneuropathies / Q000209:etiology*; D014883:Water-Electrolyte Imbalance / Q000150:complications
D007004:Hypoglycemic Agents; D009419:Nerve Tissue Proteins
Patogenez diabeticheskoĭ polinevropatii